Skip to main content
. 2019 Aug 14;9(22):6354–6368. doi: 10.7150/thno.34008

Figure 1.

Figure 1

Characterization of iMSC and adMSC. (A) Flow cytometric analysis of surface markers suggested that iMSC were positive for well-known MSC markers, including CD44, CD73, and CD105, but not for endothelial or hematopoietic markers CD11b, CD34, and CD45. (B) Flow cytometric analysis of surface markers indicated that adMSC exhibited CD29, CD44, and CD90 but not for CD31, CD34, and HLA-DR.